A Cross-over Relative Bioavailability (RBA) Study of LY03005 vs Pristiq ®

Condition:   Major Depressive Disorder Interventions:   Drug: LY03005;   Drug: Pristiq Sponsor:   Luye Pharma Group Ltd. Recruiting

Source: ClinicalTrials.gov - November 30, 2017 Category: Research Source Type: clinical trials